遗传代谢性肝病患者临床和基因突变特征分析*

doi:10.3969/j.issn.1672-5069.2022.01.018

实用肝脏病杂志 ›› 2022, Vol. 25 ›› Issue (1): 70-73.doi: 10.3969/j.issn.1672-5069.2022.01.018

遗传代谢性肝病患者临床和基因突变特征分析^*

王帅, 张威, 张帆, 钱珍, 王亚如, 辛雪萍

471003 河南省洛阳市河南科技大学第三附属医院/洛阳东方医院消化内科(王帅,张威,张帆,王亚如,辛雪萍);第一附属医院消化内科(钱珍)

收稿日期:2021-06-20 发布日期:2022-01-12
通讯作者: 张帆,E-mail: zf77361@aliyun.com
作者简介:王帅,男,34岁,硕士研究生,主治医师,讲师。E-mail: 903599931@qq.com
基金资助:
^* 洛阳市科技计划项目(项目编号:2070002A)

Clinical features and gene mutation in patients with inherited metabolic liver diseases

Wang Shuai, Zhang Wei, Zhang Fan, et al

Department of Gastroenterology, Third Affiliated Oriental Hospital to Henan University of Science and Technology, Luoyang 471003, Henan Province, China

Received:2021-06-20 Published:2022-01-12

摘要/Abstract

摘要： 目的总结过去20年洛阳市各大医院诊治的遗传代谢性肝病(IMLD)患者的临床特征。方法 2000～2021年期间洛阳市各大医院诊治的IMLD患者16例,总结、分析其临床特征。结果在16例IMLD患者中,男性10例,女性6例,平均年龄为(26±15)岁;其中金属代谢障碍性疾病8例(肝豆状核变性7例、遗传性血色病1例),遗传性高胆红素血症3例(Gilbert综合征2例、Dubin-Johnson 综合征1例),遗传性胆汁淤积症4例【良性复发性肝内胆汁淤积症(BRIC) 2例、Alagille综合征1例、Citrin缺乏症1例】和糖原累积病1例;7例肝豆状核变性患者分别来自4个家族,主要为ATP7B基因突变;遗传性血色病为HFE基因突变,Gilbert综合征为UGT1A1基因突变,Dubin-Johnson综合征为ABCC2基因突变,BRIC为ATP8B1基因突变,Alagille综合征为JAG1基因突变,Citrin缺乏症为SLC25A13基因突变,糖原累积病为G6Pase基因突变。结论 IMLD以肝豆状核变性较常见,大多IMLD的诊断需要依靠临床资料综合和基因检测。

关键词: 遗传代谢性肝病, 临床特征, 基因突变

Abstract: Objective The aim of this study was to summarize the clinical features and gene mutation in patients with inherited metabolic liver diseases (IMLD). Methods 16 patients with IMLD were encountered in five tertiary hospital in Luoyang between 2000 and 2021, and the clinical materials and gene sequencing were reviewed retrospectively. Results Out of the 16 patients with IMLD, 10 were male and 6 were female, with the average age of(26±15)yr at presentation, including metal metabolic disorders in 8 cases (Wilson's disease in 7, hereditary haemochromatosis in 1), hereditary hyperbilirubinemias in 3 (Gilbert syndrome in 2, Dubin-Johnson syndrome in 1), hereditary cholestasis in 4 [benign recurrent intrahepatic cholestasis (BRIC) in 2, Alagille syndrome in 1 and Citrin deficiency 1 case) and glycogen storage disease in 1 case; 7 patients with Wilson's disease were from 4 families mainly with ATP7B mutation and the patients with hereditary haemochromatosis had HFE mutation, Gilbert syndrome had UGT1A1 mutation, Dubin-Johnson syndrome had ABCC2 mutation, BRIC had ATP8B1 mutation, Alagille syndrome had JAG1 mutation, Citrin deficiency had SLC25A13 mutation and glycogen storage disease had G6Pase mutation. Conclusion The Wilson's disease is common in patients with IMLD, and the diagnosis depends greatly on the clinical materials and gene sequencing.

Key words: Inherited metabolic liver disease, Clinical feature, Gene sequencing

王帅, 张威, 张帆, 钱珍, 王亚如, 辛雪萍. 遗传代谢性肝病患者临床和基因突变特征分析^*[J]. 实用肝脏病杂志, 2022, 25(1): 70-73.

Wang Shuai, Zhang Wei, Zhang Fan, et al. Clinical features and gene mutation in patients with inherited metabolic liver diseases[J]. Journal of Practical Hepatology, 2022, 25(1): 70-73.

参考文献

[1] Vitale G, Gitto S, Vukotic R, et al. Familial intrahepatic cholestasis: New and wide perspectives. Dig Liver Dis, 2019, 51(7):922-933.
[2] Bryson TE, Anglin CM, Bridges PH, et al. Nuclease-mediated gene therapies for inherited metabolic diseases of the liver. Yale J Biol Med, 2017, 90(4):553-566.
[3] Bull PC, Thomase GR, Rommens JM, et al. The Wilson disease gene is a putative copper transporting p-type atpase similar to the menkes gene. Nat Genet, 1993, 5(4):327-337.
[4] Daniel FW, James SD. Atp7b variant penetrance explains differences between genetic and clinical prevalence estimates for Wilson disease. Hum Genet, 2020, 139(8):1065-1075.
[5] Marie F, Caroline D. The psychopharmacology of Wilson disease and other metabolic disorders. Handb Clin Neurol, 2019, 165(1):191-205.
[6] Chia YW, Jodie LB. Liver iron sensing and body iron homeostasis. Blood, 2019, 133(1):18-29.
[7] Grosse SD, Gurrin LC, Bertalli NA, et al. Clinical penetrance in hereditary hemochromatosis: Estimates of the cumulative incidence of severe liver disease among hef c282y homozygotes. Genet Med, 2018, 20(4):383-389.
[8] Wagner KH, Shiels RG, Lang CA, et al. Diagnostic criteria and contributors to Gilbert's syndrome. Crit Rev Clin Lab Sci, 2018, 55(2):129-139.
[9] 白洁,郑素军. 重视和推进对遗传代谢性肝病的认识和研究. 实用肝脏病杂志, 2021, 24(2):153-155.
[10] Manlio T, Claudia C, Maria M, et al. Hepatotoxicity caused by mebendazole in a patient with Gilbert's syndrome. J Clin Pharm Ther, 2019, 44(6):985-987.
[11] Mitchell E, Gilbert M, Loomes KM. Alagille syndrome. Clin Liver Dis, 2018, 22(4):625-641.
[12] Baker A, Kerkar N, Todorova L, et al. Systematic review of progressive familial intrahepatic cholestasis. Clin Res Hepatol Gastroenterol, 2019, 43(1):20-36.
[13] Luketic VA, Shiffman ML. Benign recurrent intrahepatic cholestasis. Clin Liver Dis, 2004, 8(1):133-149.
[14] 汪佩文, 董育玮, 李郑红, 等. 94例不明原因肝功能异常患者临床与肝组织病理学分析. 实用肝脏病杂志, 2018, 21(2):225-228.
[15] Stenson PD, Mort M, Ball EV, et al. The human gene mutation database: Towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet, 2017, 136(6):665-677.
[16] Kajihara S, Matsuhashi S, Yamamoto K, et al. Exon redefinition by a point mutation within exon 5 of the glucose-6-phosphatase gene is the major cause of glycogen storage disease type 1a in Japan. Am J Hum Genet, 1995, 57(3):549-555.
[17] 白洁, 任艳, 梁晨, 等. 1996～2020年北京佑安医院遗传代谢性肝病住院患者流行病学特征分析. 实用肝脏病杂志, 2021, 24 (2):164-167.
[18] Lei KJ, Shelly LL, Pan CJ, et al.Mutations in the glucose-phosphatase gene that cause glycogen storage disease type 1a.Science, 1993, 262(5133):580-583.
[19] Reem D, Ayman S, Shatha G, et al. Periodontal manifestation of type 1b glycogen storage disease: A rare case report. Clin Adv Periodontics, 2020, 10(3):150-154.
[20] Naim A, Samer G. A perspective on RNA interference-based therapeutics for metabolic liver diseases. Expert Opin Investig Drugs, 2021, 30(3):237-244.

遗传代谢性肝病患者临床和基因突变特征分析^*

Clinical features and gene mutation in patients with inherited metabolic liver diseases

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	何胜夫, 汪保灿, 范建高, 汪余勤. 胆源性肝损伤临床特征分析及治疗手段探讨[J]. 实用肝脏病杂志, 2022, 25(1): 100-103.
[2]	李变利, 徐丽红. 药物性肝损伤、药物诱导性自身免疫性肝炎和自身免疫性肝炎鉴别诊断研究进展^*[J]. 实用肝脏病杂志, 2021, 24(4): 460-463.
[3]	利振坤, 何吕芬, 李欢, 符晓莹, 王身华, 吴智明. 慢加急性肝衰竭并发侵袭性真菌感染患者临床特点及其影响因素分析[J]. 实用肝脏病杂志, 2021, 24(4): 520-523.
[4]	王梦雨, 杨蕊旭, 范建高. 重视代谢相关脂肪性肝病的特征与预后临床研究^*[J]. 实用肝脏病杂志, 2021, 24(3): 308-311.
[5]	刘松涛, 孟庆华, 闾军, 刘梅, 许媛, 周建新, 胡中杰. 淋巴瘤化疗诱发肝衰竭患者临床特点与预后分析[J]. 实用肝脏病杂志, 2021, 24(3): 383-386.
[6]	孔雪杰, 李江, 李昊天, 李绪桐, 郜玉峰. 不同肝病基础的慢加急性肝衰竭患者临床特征和预后评分模型预测效能比较[J]. 实用肝脏病杂志, 2021, 24(3): 387-390.
[7]	高慧茹, 高会斌, 彭昭, 王璐, 霍小辉. 乙型肝炎肝硬化并发食管胃底静脉曲张破裂出血患者临床特征及影响因素分析[J]. 实用肝脏病杂志, 2021, 24(3): 395-398.
[8]	李华, 温江华, 吴英春, 潘宇翔. 酒精性肝硬化患者临床特征分析[J]. 实用肝脏病杂志, 2021, 24(3): 411-414.
[9]	白洁, 郑素军. 重视和推进对遗传代谢性肝病的认识和研究[J]. 实用肝脏病杂志, 2021, 24(2): 153-155.
[10]	邓玉婷, 魏民华, 周俊英. Gilbert综合征研究进展[J]. 实用肝脏病杂志, 2021, 24(2): 156-159.
[11]	白洁, 任艳, 梁晨, 汤珊, 刘念晨, 白丽, 刘霜, 郑素军, 段钟平. 1996～2020年北京佑安医院遗传代谢性肝病住院患者流行病学特征分析[J]. 实用肝脏病杂志, 2021, 24(2): 164-167.
[12]	孙文霞, 伍树芝. IgG4相关性硬化性胆管炎100例临床特征分析[J]. 实用肝脏病杂志, 2021, 24(1): 83-86.
[13]	张健荣, 顾尔莉, 王忠成, 施亚军. 自身免疫性肝炎、原发性胆汁性胆管炎及其重叠综合征患者临床特征比较^*[J]. 实用肝脏病杂志, 2020, 23(6): 829-832.
[14]	刘松涛, 李娟, 于红卫, 侯维, 胡中杰. 9例以肝功能异常起病的恶性淋巴瘤患者临床特征分析[J]. 实用肝脏病杂志, 2020, 23(5): 650-653.
[15]	丁冬胜, 涂丹娜, 王丽, 何茹. 儿童IgG4相关自身免疫性肝炎临床与病理特征分析^*[J]. 实用肝脏病杂志, 2020, 23(1): 34-37.